|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Amylin Pharmaceuticals Inc., of San Diego, said initial purchasers in its recent private placement of $150 million of 2.25 percent convertible senior notes due in 2008 elected to exercise their option to purchase another $25 million in principal amount of the notes. The closing for the additional $25 million purchase is expected Tuesday. Amylin intends to use the proceeds for research and development, the planned commercialization of its diabetes product, Symlin, pending regulatory approvals, and general corporate purposes, it said. (See BioWorld Today, June 18, 2003.)
o Antisoma plc, of London, said it would complete its pivotal Phase III SMART study of R1549 ...
Related newspaper, magazine, and journal articles:
|
|
Article: S&P Rates San Diego Area Loc Govts, CA TRANs SP-1+ ...
Business Wire;
June 3, 1998 ;
700+ words
... ... its 'SP-1'-plus rating to San Diego Area Local Governments, Calif ... 35 school districts located in San Diego County. Each school district ... district must set-aside 50% of the principal amount of their respective note payment ...
|
|